Paratus Sciences is unlocking novel disease targets and accelerating drug discovery by leveraging the extraordinary adaptive biology of bats. Bats’ numerous evolutionary adaptations allow them to resist developing many diseases, and also endow them with remarkable physiological fitness and longevity. At Paratus, we are utilizing these unique biological advantages as a roadmap to potentially address a broad spectrum of significant challenges to human health.
Our proprietary discovery platform, which fully integrates cell biology, genomics, and informatics, empowers us with massive data inputs through which we are able to compare the evolved patterns of disease resistance and health management in bats with patterns of disease development and progression in humans. Through this data-driven comparative analysis, we aim to rapidly identify and prioritize novel targets and develop innovative therapeutics that can mimic bats’ adaptations in order to address or prevent human disease.
Our initial discovery pipeline focuses on immunology and inflammation, and cardiometabolism, with the potential to expand to additional therapeutic areas, including oncology and aging. We also have an ongoing research collaboration with the National Institute of Allergy and Infectious Disease to explore virology applications with our approach.
Our top-tier investor syndicate, including Polaris Partners, ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, and Alexandria Venture Investments, and the $100 million we’ve raised to date, demonstrate a strong belief in the potential of our approach to impact and improve human health.
Company Details
- Employees
- 18
- Founded
- -
- Address
- New York , Ny, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.paratussciences.com
- HQ
- New York , NY
Paratus Sciences Questions
Paratus Sciences's website is https://www.paratussciences.com
Paratus Sciences's LinkedIn profile is https://www.linkedin.com/company/paratus-sciences
Paratus Sciences has
18 employees.
View email and phone details for 18
employees at Paratus Sciences.
Paratus Sciences's industry is
Biotechnology Research
Paratus Sciences's top competitors are
Clavystbio,
Neptune Bio,
Tessa Therapeutics Ltd,
Aethon Therapeutics,
Nilo Therapeutics,
Renbio,
Bluerock Therapeutics,
Hummingbird Bioscience,
Kallyope,
Polaris Partners.
Paratus Sciences's categories are Biotechnology Research
Paratus Sciences's founding year is 2021
